Post-transplant lymphoproliferative disorder presenting as supraglottitis following pediatric heart transplantation treated with EBV-specific cytotoxic T-lymphocytes.
Epstein-Barr virus
cardiac
cytotoxic T-lymphocytes
post-transplant lymphoproliferative disorder
transplantation
Journal
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
ISSN: 1557-3117
Titre abrégé: J Heart Lung Transplant
Pays: United States
ID NLM: 9102703
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
received:
18
10
2021
revised:
14
02
2022
accepted:
23
02
2022
pubmed:
5
4
2022
medline:
26
5
2022
entrez:
4
4
2022
Statut:
ppublish
Résumé
We present the case of a 4 year-old boy post heart transplantation who presented with signs and symptoms of critical airway obstruction and was initially diagnosed with infective supraglottitis. Following re-presentation and biopsy, this was confirmed as post-transplant lymphoproliferative disorder (PTLD) in an unusual site; laryngeal PTLD is rare. The patient failed standard therapy and ultimately was successfully treated with EBV-specific cytotoxic T lymphocytes (CTL). This case describes a rare presentation of PTLD which required a novel treatment approach including elective tracheostomy prior to CTL therapy. The treatment was successful and the patient was decannulated prior to discharge following 4 negative biopsies, the most recent 6 months following treatment completion. The case also highlights the importance of extra-vigilance in the post-transplant population and of a collaborative approach between multiple specialties across two separate countries including the transplant center and the referral center.
Identifiants
pubmed: 35370033
pii: S1053-2498(22)01845-9
doi: 10.1016/j.healun.2022.02.019
pii:
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
708-711Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.